GTx Incorporated
GTx, Inc. is a pharmaceutical company that is working on drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes. Its drugs in development include enobosarm (ostarine) and GTx-758. In 2016 GTx began Phase II trials, to see if enosobarm might be effective to treat stress urinary incontinence in women. In June 2019, GTx combined with Oncternal Therapeutics in a reverse merger. The combined company will operate under the name Oncternal Therapeutics, Inc.
Wikipage disambiguates
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
GTx Incorporated
GTx, Inc. is a pharmaceutical company that is working on drugs in the selective estrogen receptor modulator (SERM) and selective androgen receptor modulator (SARM) classes. Its drugs in development include enobosarm (ostarine) and GTx-758. In 2016 GTx began Phase II trials, to see if enosobarm might be effective to treat stress urinary incontinence in women. In June 2019, GTx combined with Oncternal Therapeutics in a reverse merger. The combined company will operate under the name Oncternal Therapeutics, Inc.
has abstract
GTx, Inc. is a pharmaceutical ...... e Oncternal Therapeutics, Inc.
@en
founding date
1997-09-24
founding year
industry
product
type
Link from a Wikipage to an external page
Wikipage page ID
31,616,717
page length (characters) of wiki page
Wikipage revision ID
1,019,215,434
Link from a Wikipage to another Wikipage
foundation
1997-09-24
homepage
industry
name
GTx, Inc.
@en
products
traded as
NASDAQ:ONCT
@en
type
wikiPageUsesTemplate
subject
hypernym
comment
GTx, Inc. is a pharmaceutical ...... e Oncternal Therapeutics, Inc.
@en
label
GTx Incorporated
@en
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
GTx, Inc.
@en